ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
3.52 / 10
Netural
Technically, ONCY holds a 3.52/10 score with a neutral rating. The most recent five-day analysis shows two bearish signals (MACD Death Cross and Long Upper Shadow) versus one neutral (Long Lower Shadow). Historical back-tests reveal that MACD Death Cross typically yields negative returns (-1.05%) and Long Upper Shadow has a modest 0.33% average return with a 42.2% win rate, while Long Lower Shadow offers a more encouraging 3.99% average return and 56.1% win rate. The preponderance of bearish signals tempers any short-term optimism.
Analysis Checks(1/3)
Long Upper Shadow
Score2/10
Win Rate42.22%
Hist. Signals45
Avg Return0.33%
Score2/10
Win Rate42.22%
Hist. Signals45
Avg Return0.33%
MACD Death Cross
Score1.64/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.05%
Score1.64/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.05%
Long Lower Shadow
Score6.91/10
Win Rate56.06%
Hist. Signals66
Avg Return3.99%
Score6.91/10
Win Rate56.06%
Hist. Signals66
Avg Return3.99%
Long Upper Shadow
Score2/10
Win Rate42.22%
Hist. Signals45
Avg Return0.33%
Score2/10
Win Rate42.22%
Hist. Signals45
Avg Return0.33%
Long Lower Shadow
Score6.91/10
Win Rate56.06%
Hist. Signals66
Avg Return3.99%
Score6.91/10
Win Rate56.06%
Hist. Signals66
Avg Return3.99%
MACD Death Cross
Score1.64/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.05%
Score1.64/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.05%
Technical Analysis of ONCY?
- ONCY presents a Netural setup with a Technical Score of 3.52/10. Key technical indicators highlight an RSI of 41.39 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 0.99. Traders should monitor key support at 0.79 and resistance at 0.91.
